Pure Financial Advisors, LLC Abbott Laboratories Transaction History

Pure Financial Advisors, LLC

  • $4.25 Billion
  • Q4 2024

A detailed history of Pure Financial Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 6,979 shares of ABT stock, worth $961,078. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,979
Previous 6,268 11.34%
Holding current value
$961,078
Previous $714,000 10.5%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
BUY
$111.93 - $119.39 $79,582 - $84,886
711 Added 11.34%
6,979 $789,000
Q3 2024

Oct 29, 2024
SELL
$100.07 - $118.13 $1.04 Million - $1.23 Million
-10,417 Reduced 62.43%
6,268 $714,000
Q2 2024

Jul 18, 2024
BUY
$100.73 - $112.44 $29,413 - $32,832
292 Added 1.78%
16,685 $1.73 Million
Q1 2024

Apr 16, 2024
SELL
$109.52 - $120.96 $131,314 - $145,031
-1,199 Reduced 6.82%
16,393 $1.86 Million
Q4 2023

Jan 08, 2024
BUY
$90.19 - $110.4 $52,490 - $64,252
582 Added 3.42%
17,592 $1.94 Million
Q3 2023

Oct 10, 2023
BUY
$95.53 - $114.62 $24,933 - $29,915
261 Added 1.56%
17,010 $1.65 Million
Q2 2023

Jul 10, 2023
BUY
$100.78 - $112.29 $7,558 - $8,421
75 Added 0.45%
16,749 $1.83 Million
Q1 2023

Apr 11, 2023
BUY
$96.86 - $114.01 $19,275 - $22,687
199 Added 1.21%
16,674 $1.69 Million
Q4 2022

Jan 09, 2023
BUY
$95.06 - $111.52 $5,988 - $7,025
63 Added 0.38%
16,475 $0
Q3 2022

Oct 06, 2022
BUY
$96.76 - $112.03 $10,256 - $11,875
106 Added 0.65%
16,412 $1.59 Million
Q2 2022

Jul 08, 2022
SELL
$102.07 - $123.37 $11,942 - $14,434
-117 Reduced 0.71%
16,306 $1.77 Million
Q1 2022

Apr 12, 2022
BUY
$114.02 - $139.04 $12,200 - $14,877
107 Added 0.66%
16,423 $1.94 Million
Q4 2021

Jan 12, 2022
BUY
$115.53 - $141.46 $76,480 - $93,646
662 Added 4.23%
16,316 $2.3 Million
Q3 2021

Oct 07, 2021
BUY
$116.66 - $129.06 $6,182 - $6,840
53 Added 0.34%
15,654 $1.85 Million
Q2 2021

Jul 09, 2021
SELL
$105.79 - $124.53 $18,090 - $21,294
-171 Reduced 1.08%
15,601 $1.81 Million
Q1 2021

Apr 09, 2021
SELL
$108.84 - $128.23 $119,070 - $140,283
-1,094 Reduced 6.49%
15,772 $1.89 Million
Q4 2020

Jan 12, 2021
BUY
$105.0 - $114.42 $253,050 - $275,752
2,410 Added 16.67%
16,866 $1.85 Million
Q3 2020

Oct 07, 2020
BUY
$91.64 - $111.29 $6,781 - $8,235
74 Added 0.51%
14,456 $1.57 Million
Q2 2020

Jul 08, 2020
BUY
$76.57 - $98.0 $197,167 - $252,350
2,575 Added 21.81%
14,382 $1.32 Million
Q1 2020

Apr 07, 2020
SELL
$62.82 - $91.86 $38,131 - $55,759
-607 Reduced 4.89%
11,807 $932,000
Q4 2019

Jan 09, 2020
BUY
$78.51 - $87.4 $69,088 - $76,912
880 Added 7.63%
12,414 $1.08 Million
Q3 2019

Oct 09, 2019
BUY
$81.84 - $88.74 $3,600 - $3,904
44 Added 0.38%
11,534 $965,000
Q2 2019

Jul 11, 2019
BUY
$72.88 - $85.0 $3,425 - $3,995
47 Added 0.41%
11,490 $966,000
Q1 2019

Apr 05, 2019
SELL
$66.22 - $80.06 $10,065 - $12,169
-152 Reduced 1.31%
11,443 $915,000
Q4 2018

Jan 11, 2019
BUY
$65.56 - $74.27 $3,868 - $4,381
59 Added 0.51%
11,595 $839,000
Q3 2018

Oct 04, 2018
SELL
$60.81 - $73.36 $60 - $73
-1 Reduced 0.01%
11,536 $846,000
Q2 2018

Jul 10, 2018
BUY
$57.57 - $63.54 $5,872 - $6,481
102 Added 0.89%
11,537 $704,000
Q1 2018

Apr 05, 2018
SELL
$56.27 - $63.62 $10,803 - $12,215
-192 Reduced 1.65%
11,435 $685,000
Q4 2017

Jan 10, 2018
BUY
$53.68 - $57.47 $13,581 - $14,539
253 Added 2.22%
11,627 $664,000
Q3 2017

Oct 11, 2017
BUY
$48.06 - $53.64 $546,634 - $610,101
11,374
11,374 $607,000

Others Institutions Holding ABT

# of Institutions
3,370
Shares Held
1.36B
Call Options Held
10.6M
Put Options Held
8.73M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $241B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Pure Financial Advisors, LLC Portfolio

Follow Pure Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pure Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email